Tweet
<img alt="" height="1" width="1" />
AHA: Extended Apixaban Fails to Beat Enoxaparin for VTE
MedPage Today
Explain that medically ill patients at risk for venous thromboembolism (VTE) did not obtain significant benefit from month-long treatment with apixaban (Eliquis) when compared with two weeks of treatment ...
Bristol, Pfizer clot drug fails to help ill patientsReuters
ADOPT Fails to Support Extended Oral Anticoagulation with Apixabanin High Risk ...Forbes
Pfizer-Bristol Drug Doesn't Cut Leg Clots After Hospital StayBloomberg
TheHeart.Org -MarketWatch (press release) -istockAnalyst.com (press release)
all 18 news articles »
More...